18,400 resources
By Version
By Authority
Start Prev Rows 8000 - 8200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth |
---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2381 | Specimen from a Nonsterile Site (Specimen Type) (SNOMED) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2382 | Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2383 | Absence of Skin Lesions (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2384 | Neuralgia (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2385 | Neuralgia (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2386 | Peripheral Nerve Thickening (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2387 | Nerve (Specimen Type) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2388 | Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.239 | Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.240 | Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2403 | NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2404 | Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2405 | Hepatitis D Virus Infection (Test for hepatitis D virus Antigen) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2406 | Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2407 | Firearm Injury (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2408 | Firearm Injury (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2409 | Babesiosis (Tests for B. microti IgG or Total Antibody [Titer]) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2410 | Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer]) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2411 | Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer]) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2412 | Babesiosis (Tests for Babesia species IgG or Total Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2413 | Brucellosis (Tests for Brucella species IgG Antibody by ELISA) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2414 | Cranial Nerve Involvement (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2415 | Cranial Nerve Involvement (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2416 | Unusual Change in Behavior (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2417 | Radiculitis (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2418 | Subarachnoid Hemorrhage (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2419 | Subarachnoid Hemorrhage (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2420 | Discitis (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2421 | Discitis (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2423 | Respiratory Insufficiency [Unspecified Cause] (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2424 | Respiratory Insufficiency [Unspecified Cause] (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2425 | Conjunctival Suffusion (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2426 | Leptospira species (Tests by Microscopic Observation) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2427 | Leptospirosis (Tests for Leptospira Antibody by Agglutination) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2428 | Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2429 | Conjunctival Suffusion (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2430 | Pleural effusion (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2431 | Pleural effusion (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2432 | Abdominal swelling (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2433 | Abdominal swelling (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2434 | Neck swelling (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2435 | Neck swelling (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2436 | Diaphoresis (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2437 | Diaphoresis (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2438 | Edema (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2439 | Edema (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.244 | Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2440 | Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2441 | Anthrax (Tests for Bacillus species by Culture and Identification Method) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2442 | Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2443 | Influenza A (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2444 | Influenza B (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2445 | Influenza [Unspecified] (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2446 | Influenza A (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2447 | Influenza [Unspecified] (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2448 | Influenza (Tests for unspecified influenza virus Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2449 | Influenza (Tests for influenza B virus Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2450 | Influenza (Tests for unspecified influenza virus Antigen) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2451 | Influenza (Tests for influenza B virus Antigen) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2452 | Influenza (unspecified influenza virus in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2453 | Influenza (influenza B virus in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2454 | Influenza (Tests for unspecified influenza virus by Culture and Identification Method) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2455 | Influenza (Tests for influenza B virus by Culture and Identification Method) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2456 | Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2457 | Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2458 | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2459 | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2460 | Borrelia species (Tests by Microscopic Observation) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2461 | Borrelia species (Tests by Microscopic Observation in Blood) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2462 | Spirochetes (Tests by Microscopic Observation) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2463 | Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2464 | CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2465 | CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2466 | CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2467 | CRE (Tests for Enterobacterales species Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2468 | CRE (Combination Tests that include Enterobacterales by Culture and Identification) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2469 | Tests for Carbapenem Susceptibility [Meropenem and Doripenem] | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2470 | Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2471 | Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2473 | Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2474 | Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2475 | Aortic valve stenosis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2476 | Aortic valve stenosis (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2477 | Anotia (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2478 | Microtia (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2479 | Microtia (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2480 | Anotia (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2482 | Anophthalmia (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2483 | Anophthalmia (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2484 | Microphthalmia (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2485 | Microphthalmia (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2486 | Atrial septal defect (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2487 | Atrial septal defect (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2488 | Fetal Aortic valve stenosis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2489 | Congenital Posterior Urethral Valves (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2490 | Congenital Posterior Urethral Valves (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2491 | Bladder Exstrophy (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2492 | Bladder Exstrophy (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2493 | Encephalocele (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2494 | Fetal Encephalocele (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2495 | Encephalocele (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2496 | Choanal Atresia (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2497 | Choanal Atresia (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2498 | Cloacal Exstrophy (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2499 | Cloacal Exstrophy (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2500 | Renal Agenesis or Hypoplasia (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2501 | Renal Agenesis or Hypoplasia (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2502 | Trisomy 13 (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2503 | Trisomy 13 (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2504 | Fetal Trisomy 13 (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2505 | Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2506 | Galactosemia (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2507 | Galactosemia (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2508 | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2509 | Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2510 | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2511 | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative]) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2512 | Galactosemia (Tests for Galactokinase (GALK) [Quantitative]) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2513 | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative]) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2514 | Galactosemia (Tests for GALT gene allele 1) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2515 | Galactosemia (Tests for GALT gene allele 2) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2516 | Hypospadias (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2517 | Hypospadias (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2518 | Trisomy 18 (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2519 | Fetal Trisomy 18 (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2520 | Fetal Trisomy 18 (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2521 | Trisomy 18 (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2522 | Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2523 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2524 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2525 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2526 | Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2527 | Chlamydia species [Unspecified] (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2528 | Ventricular septal defect (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2529 | Ventricular septal defect (Disorders) (ICD10CM) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2530 | Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2531 | Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2532 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2533 | Congenital Cytomegalovirus (Tests for CMV Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.268 | Mumps (Tests for mumps virus IgM Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.272 | Present or Positive Lab Result Value | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.282 | Varicella (Tests for Varicella zoster virus by Culture and Identification Method) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.283 | Varicella (Tests for Varicella zoster virus Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.285 | Encephalitis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.287 | Varicella (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.289 | Carbon Monoxide Poisoning (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.293 | Toxic Effects of Lead (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.297 | Measles (Tests for measles virus Nucleic Acid) | active | 2025-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.299 | Measles (Tests for measles virus IgM Antibody) | active | 2025-03 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.300 | Meningococcal Disease (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.301 | Shigellosis (Tests for Shigella species by Culture and Identification Method) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.307 | Leptospirosis (Tests for Leptospira IgM Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.308 | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.310 | Bacteria (Tests by Culture and Identification Method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.311 | Viruses (Tests by Culture and Identification Method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.316 | Rubella (Tests for rubella virus IgM Antibody) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.317 | Shigellosis (Tests for Shigella species Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.319 | Fungi (Tests by Culture and Identification Method) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.322 | Pesticide Related Illness (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.329 | Apnea (SNOMED) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.330 | Apnea (ICD10CM) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.333 | Shigellosis (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.335 | Influenza (Tests for influenza A virus by Culture and Identification Method) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.336 | Influenza (Tests for influenza A or B virus Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.340 | Influenza (influenza A or B virus in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.341 | Campylobacteriosis (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.342 | Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.343 | Campylobacteriosis (Tests for Campylobacter species Nucleic Acid) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.344 | Campylobacteriosis (Tests for Campylobacter species Antigen) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.349 | Hepatitis A (Tests for hepatitis A virus IgM Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.353 | Diarrhea (SNOMED) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.356 | HIV Infection (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.359 | Botulism (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.362 | Hansen’s Disease (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.365 | Silicosis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.366 | Silicosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.371 | Cryptosporidiosis (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.372 | Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.375 | Cyclosporiasis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.376 | Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.379 | Giardiasis (Tests for Giardia species Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.384 | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.386 | Vibriosis (Organism or Substance in Lab Results) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.388 | Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.390 | Trichinellosis (Tests for Trichinella species Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.395 | Syphilis (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.396 | Syphilis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.398 | Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.399 | Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.40 | STEC Infection (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.400 | Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.401 | Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.403 | Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.405 | Hantavirus Infection and Diseases (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.407 | Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.408 | Hepatitis B Virus Infection (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.422 | Tuberculosis (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.427 | STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.43 | Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.436 | Coccidioidomycosis (Tests for Coccidioides species IgM Antibody) | active | 2024-01 | hl7 |